HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Rainer Haas Selected Research

Refractory Anemia with Excess of Blasts (RAEM)

7/2015Change of prognosis of patients with myelodysplastic syndromes during the last 30 years.
12/2013Serum hepcidin measured with an improved ELISA correlates with parameters of iron metabolism in patients with myelodysplastic syndrome.
12/2006Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes.
1/2006Refractory anaemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposals.
2/2004Ineffective hematopoiesis linked with a mitochondrial tRNA mutation (G3242A) in a patient with myelodysplastic syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Rainer Haas Research Topics

Disease

27Myelodysplastic Syndromes (Myelodysplastic Syndrome)
04/2015 - 10/2002
20Neoplasms (Cancer)
02/2012 - 01/2002
16Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2015 - 11/2002
11Infection
12/2015 - 08/2003
11Multiple Myeloma
07/2013 - 02/2004
6Hematologic Neoplasms (Hematological Malignancy)
04/2011 - 07/2002
5Refractory Anemia with Excess of Blasts (RAEM)
07/2015 - 02/2004
5Leukemia
01/2014 - 01/2003
4Inflammation
12/2013 - 05/2005
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2012 - 11/2002
4Residual Neoplasm
10/2012 - 02/2004
4Multiple Sclerosis
11/2011 - 04/2008
4Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2010 - 09/2002
4Small Cell Lung Carcinoma (Small Cell Lung Cancer)
11/2006 - 08/2004
3Gastritis
11/2013 - 06/2002
3Body Weight (Weight, Body)
08/2011 - 01/2002
3Lymphoma (Lymphomas)
01/2010 - 11/2002
3Refractory Anemia
12/2006 - 10/2002
3Breast Neoplasms (Breast Cancer)
04/2006 - 01/2002
2Carcinoma (Carcinomatosis)
11/2013 - 10/2005
2Duodenal Ulcer (Curling's Ulcer)
11/2013 - 06/2002
2Thrombocytopenia (Thrombopenia)
06/2012 - 11/2009
2Stomach Diseases
01/2010 - 01/2009
2Chromosome Aberrations (Chromosome Abnormalities)
09/2009 - 01/2008
2Occupational Diseases (Occupational Disease)
03/2009 - 08/2008
2Lung Neoplasms (Lung Cancer)
01/2008 - 01/2005
2Neutropenia
01/2008 - 10/2006
2Fibrosis (Cirrhosis)
08/2007 - 06/2005
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2007 - 04/2005
2Blast Crisis (Blast Phase)
10/2006 - 01/2003
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
09/2002 - 08/2002
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2013
1Iron Overload
08/2012
1Graft vs Host Disease (Graft-Versus-Host Disease)
03/2012
1Colorectal Neoplasms (Colorectal Cancer)
02/2012
1Relapsing-Remitting Multiple Sclerosis
11/2011

Drug/Important Bio-Agent (IBA)

6ParaffinIBA
01/2009 - 01/2002
5Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2010 - 09/2002
5Formaldehyde (Formol)FDA Link
11/2006 - 01/2002
4natalizumab (Tysabri)FDA Link
11/2011 - 04/2008
4Valproic Acid (Valproate, Semisodium)FDA LinkGeneric
08/2011 - 09/2004
3IntegrinsIBA
12/2015 - 07/2002
3bortezomib (Velcade)FDA Link
08/2011 - 12/2007
3Messenger RNA (mRNA)IBA
07/2011 - 01/2003
3DNA (Deoxyribonucleic Acid)IBA
08/2007 - 01/2002
3rituximab (Mabthera)FDA Link
08/2006 - 09/2002
3Histone Deacetylases (Histone Deacetylase)IBA
01/2006 - 09/2004
3Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2006 - 09/2004
2Membrane Proteins (Integral Membrane Proteins)IBA
08/2015 - 09/2009
2Azacitidine (5 Azacytidine)FDA Link
04/2015 - 08/2011
2Ferritins (Ferritin)IBA
12/2013 - 08/2012
2Hemoglobins (Hemoglobin)IBA
12/2013 - 01/2006
2IronIBA
12/2013 - 07/2002
2AntigensIBA
11/2013 - 01/2009
2ProteomeIBA
05/2013 - 01/2007
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2013 - 08/2004
2Tacrolimus (Prograf)FDA LinkGeneric
03/2012 - 08/2003
2CytokinesIBA
07/2011 - 01/2009
2Fibroblast Growth Factor 7FDA Link
04/2011 - 07/2007
2Interleukin-6 (Interleukin 6)IBA
10/2010 - 06/2006
2Benzene (Benzole)IBA
03/2009 - 08/2008
2bendamustineFDA Link
12/2007 - 08/2002
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
11/2006 - 01/2005
2Histidine (L-Histidine)FDA Link
11/2006 - 09/2003
2sulindac sulfone (exisulind)IBA
11/2006 - 06/2005
2fragile histidine triad proteinIBA
11/2006 - 01/2005
2pegfilgrastim (Neulasta)FDA Link
10/2006 - 02/2006
2Phosphotransferases (Kinase)IBA
10/2006 - 09/2003
2Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
05/2004 - 02/2004
1Diethylhexyl Phthalate (DEHP)IBA
01/2014
1tranilast (N 5')IBA
12/2013
1hepcidinIBA
12/2013
1Transferrin Receptors (Transferrin Receptor)IBA
12/2013
1ErythropoietinFDA Link
12/2013
1C-Reactive ProteinIBA
12/2013
1Transferrin (beta 2 Transferrin)IBA
12/2013
1Carbon MonoxideIBA
11/2013
1CalciumIBA
05/2013
1Fibrinogen (Factor I)FDA Link
05/2013
1HLA-C Antigens (HLA-C)IBA
12/2012
1CD40 Ligand (CD40L)IBA
06/2012
1Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
03/2012
1mycophenolate mofetil (Cellcept)FDA LinkGeneric
03/2012
1N 30IBA
02/2012
1(5- fluoro- 2- methyl- 1- (4- pyridyl)methylene- 3- (N- benzyl)- indene)- acetamide hydrochlorideIBA
02/2012
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
09/2011
1Diclofenac (SR 38)FDA LinkGeneric
09/2011
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
09/2011
1sulindac sulfideIBA
09/2011
1Busulfan (Busulfex)FDA Link
08/2011
1Melphalan (Alkeran)FDA LinkGeneric
08/2011

Therapy/Procedure

21Drug Therapy (Chemotherapy)
10/2012 - 01/2002
18Stem Cell Transplantation
07/2015 - 01/2002
5Transplants (Transplant)
04/2015 - 10/2002
3Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
08/2011 - 04/2008
3Transplantation (Transplant Recipients)
01/2007 - 02/2004
2Hematopoietic Stem Cell Transplantation
04/2015 - 05/2009
2Platelet Transfusion (Blood Platelet Transfusions)
06/2012 - 11/2009
1Salvage Therapy
04/2015
1Withholding Treatment
02/2012